Where does Adcendo's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Adcendo's 2 recorded funding rounds.

Premier Alternatives

Adcendo

Drug Discovery · Frederiksberg, Denmark · Founded 2017 · Privately Held (backing)

Developer of antibody-drug conjugates designed to create new medicines for cancer patients with significant unmet needs. Adcendo is based in Frederiksberg, Denmark and was founded in 2017. It was valued at $210 million at its later-stage round in Nov 2024, the last priced event on record. It has raised $316 million across 2 recorded rounds; the latest was a $134 million Series B in Nov 2024.

PMV mark · valuation

$209.9M

Oct 2026

Priced at

its later-stage round

Nov 2024

Total raised

$315.9M

Last round

Later Stage VC (Series B)

Nov 2024

Cap table — not yet on record

Adcendo's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Adcendo with a free account

·The complete investor list: 21 names
·Watch Adcendo: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Adcendo

Where does Adcendo's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Adcendo's 2 recorded funding rounds.